Researchers from CiQUS and the Institute of Health Research of Santiago de Compostela optimized the available pharmacological treatment for ischemic stroke using biomimetic nanoparticles. Their study, “Lyophilized platelet-derived nanocarrier-based thrombolytic

B. Pelaz and P. Del Pino are presenting the recent work of the BNT lab at the Beilstein Nanotechnology Symposium 2024, in Rüdesheim, Germany, from 3-5 September 2024. https://www.beilstein-institut.de/en/symposia/archive/nanotechnology/nanomedicine-2024/

Manuel successfully defended his doctoral dissertation titled “Engineering core-shell plasmonic nanoMOFs: synthetic methodologies and applications” under the guidance of the supervisor Pablo del Pino. The defense took place on November